Cumberland Pharmaceuticals Inc (CPIX)
1.20
+0.06
(+5.26%)
USD |
NASDAQ |
Nov 05, 16:00
1.20
0.00 (0.00%)
After-Hours: 16:11
Cumberland Pharmaceuticals Profit Margin (Quarterly): -11.02% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -11.02% |
| March 31, 2024 | -22.90% |
| December 31, 2023 | -67.30% |
| September 30, 2023 | -10.40% |
| June 30, 2023 | 8.01% |
| March 31, 2023 | 2.08% |
| December 31, 2022 | -26.75% |
| September 30, 2022 | -3.58% |
| June 30, 2022 | -12.97% |
| March 31, 2022 | -12.40% |
| December 31, 2021 | -46.25% |
| September 30, 2021 | -13.07% |
| June 30, 2021 | 13.57% |
| March 31, 2021 | 1.58% |
| December 31, 2020 | -8.61% |
| September 30, 2020 | -5.21% |
| June 30, 2020 | -9.57% |
| March 31, 2020 | -12.67% |
| December 31, 2019 | -10.32% |
| September 30, 2019 | -28.17% |
| June 30, 2019 | -5.84% |
| March 31, 2019 | -0.85% |
| December 31, 2018 | -105.7% |
| September 30, 2018 | -19.35% |
| June 30, 2018 | -7.09% |
| Date | Value |
|---|---|
| March 31, 2018 | -27.71% |
| December 31, 2017 | -6.87% |
| September 30, 2017 | -6.64% |
| June 30, 2017 | -59.54% |
| March 31, 2017 | -13.22% |
| December 31, 2016 | -8.26% |
| September 30, 2016 | 1.21% |
| June 30, 2016 | -0.65% |
| March 31, 2016 | -3.27% |
| December 31, 2015 | 1.88% |
| September 30, 2015 | 1.61% |
| June 30, 2015 | 4.56% |
| March 31, 2015 | 0.53% |
| December 31, 2014 | 7.17% |
| September 30, 2014 | 7.67% |
| June 30, 2014 | 7.41% |
| March 31, 2014 | 3.54% |
| December 31, 2013 | -18.39% |
| September 30, 2013 | -12.56% |
| June 30, 2013 | -9.02% |
| March 31, 2013 | 8.33% |
| December 31, 2012 | 13.18% |
| September 30, 2012 | 14.92% |
| June 30, 2012 | 14.10% |
| March 31, 2012 | 4.13% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-67.30%
Minimum
Dec 2023
13.57%
Maximum
Jun 2021
-13.04%
Average
-10.40%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.48% |
| Return on Assets | -12.38% |
| Return on Invested Capital | -22.95% |
| Gross Profit Margin (Quarterly) | 82.63% |
| Operating Margin (Quarterly) | -10.42% |
| Return on Net Operating Assets | -20.82% |